SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Spectrum Pharmaceuticals, Inc (SPPI) -- Ignore unavailable to you. Want to Upgrade?

To: gonnahappensoon who wrote (21)9/6/2012 11:08:05 AM
From: barondog1 Recommendation  Respond to of 41
 
Hey guys, thanks for the heads up on this board. With regard to the upcoming catalyst post, you left off FDA discussions about Eoquin. I think the fact that they are not currently enrolling for the trial may be a sign that they have positive indications form the FDA or their advisers that the combination of the two trials has significant merit. Hope to hear something soon about that as well.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News